By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

M. D. Anderson Cancer Center 

1515 Holcombe Boulevard

Houston  Texas  77030  U.S.A.
Phone: 800-392-1611 or 713-792-6161 Fax:


SEARCH JOBS




Collaborations

Xeotron Corporation 





Company News
M. D. Anderson Cancer Center and Biocept, Inc. Scientists to Present Poster at American Society of Clinical Oncology on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breast Cancer Patients 6/2/2011 10:20:34 PM
Vaccine May Help Treat Advanced Melanoma: M. D. Anderson Cancer Center 6/2/2011 7:44:46 AM
Rosetta Genomics Ltd. (ROSG) Release: M. D. Anderson Cancer Center Researchers Demonstrate Power of miRview(TM) Mets to Identify Tissue of Origin in Carcinoma of Unknown Primary 5/2/2011 8:52:12 AM
Herbert A. Fritsche, Ph.D., Former M. D. Anderson Cancer Center Professor and Scientist, Joins Health Discovery Corporation (DWCM.OB) as Senior Vice President and Chief Science Officer 9/2/2010 10:58:56 AM
Similar Survival with Two Ovarian Cancer Strategies, M. D. Anderson Cancer Center Study Published in The New England Journal of Medicine 9/2/2010 6:50:18 AM
Toward the Future of Radiation Therapy: M. D. Anderson Cancer Center's Proton Therapy Center Pioneers Pencil Beam Technology for Cancer Patient Care 8/3/2010 8:31:33 AM
Rosetta Genomics Ltd. (ROSG) Release: Data Presented at American Society of Clinical Oncology 2010 by M. D. Anderson Cancer Center Demonstrate the ability of miRvie(TM) mets to Identify the Most Likely Origin of Metastases in Cancer of Unknown Primary 6/7/2010 6:29:54 PM
Rosetta Genomics Ltd. (ROSG) Release: Data Presented at American Society of Clinical Oncology 2010 by M. D. Anderson Cancer Center Researchers Demonstrate the ability of miRvie(TM) mets to Identify the Most Likely Origin of Metastases in Cancer of Unknown Primary 6/7/2010 2:05:48 PM
Rosetta Genomics Ltd. (ROSG) and Collaborators From M. D. Anderson Cancer Center And University of Heidelberg to Present New Data at American Society of Clinical Oncology 2010 on Clinical Studies Involving miRview mets 5/26/2010 9:36:00 AM
Naviscan, Inc.: Researchers at M. D. Anderson Cancer Center Show That Positron Emission Mammography (PEM) Helps Evaluate Early Response to Neoadjuvant Chemotherapy 5/26/2010 8:44:02 AM
12345678910...
//-->